News

2024
2023
2022
2021
2020
2018
Aug 13 2024

Tevard Biosciences to Move Corporate Headquarters to Lilly Gateway Labs in Boston’s Seaport

Read more
Jun 24 2024

Industry Veteran and RNA Therapeutics Expert, John Maraganore, Joins Tevard Biosciences as Strategic Advisor and Board Observer

Read more
Nov 13 2023

Tevard Biosciences appoints Dr. Gregory Robinson as Chief Scientific Officer

Read more
Feb 28 2023

Tevard Biosciences announces collaboration with Vertex to develop novel tRNA-based therapies for Duchenne muscular dystrophy

Read more
Aug 03 2022

Tevard Biosciences Appoints Zoya Ignatova to Its Scientific Advisory Board

Read more
Apr 26 2022

Tevard CEO Awarded Henri Termeer Fellowship

Read more
Mar 31 2022

Tevard Biosciences licenses mRNA Amplifier technology from Johns Hopkins University

Read more
Mar 09 2022

Tevard Biosciences Appoints Paul Schimmel, Susan Ackerman, and Nicholas Ingolia to Its Scientific Advisory Board

Read more
Feb 25 2022

tRNA therapeutics burst onto startup scene

Read more
Sep 20 2021

tRNA therapies could help restore proteins lost in translation

Read more